CLINICAL_TRIALS
trial_result
· 2024-04-05
Clinical Trial Update: Chemoprevention of Gastric Carcinogenesis [Phase 2]
Summary
A Phase 2 chemoprevention trial for gastric carcinogenesis has completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Gastric Cancer, Gastric Intestinal Metaplasia | Phase 2 | Status: COMPLETED | Results posted: 2024-04-05